Approval · Notice of Compliance 174 · 2003
BUSULFEX: Notice of Compliance 174
Issued July 21, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 174
- Date
- July 21, 2003
- Company
- Esp Pharma, Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUSULFEX | 02240602 | Cancelled Post Market |
Medicinal ingredients
- BUSULFAN 6 MG per ML